Rare diseases
Investigational molecules
Locations
Nussdorfer Platz 8, Doebling, 1190 Vienna, Austria
ABCSG GmbH demonstrates a focused commitment to advancing therapeutic strategies in breast cancer management. The organisation coordinates comprehensive clinical investigations that explore innovative treatment approaches for patients with hormone-sensitive disease. Their research encompasses the evaluation of endocrine therapy regimens and their optimal duration in clinical practice.
The sponsor's research network extends across multiple European countries, facilitating large-scale collaborative studies that aim to refine treatment standards for women with early-stage breast cancer. Their investigations focus on determining the most effective therapeutic durations to improve long-term patient outcomes while considering quality of life considerations.
ABCSG GmbH runs clinical trials in conditions such as Hormone receptor positive breast cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
